SCHEMBL5819362

SCHEMBL5819362

CN1CCC(O)(c2nc(-c3ccccc3F)c(-c3ccnc(NC4CC4)n3)s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.41
RET P07949 1/20 0.41
CDK4 P11802 4/20 0.39
CCND1 P24385 4/20 0.39
CDK1 P06493 3/20 0.39
CCNB1 P14635 3/20 0.39
CCNA2 P20248 3/20 0.39
CDK2 P24941 3/20 0.39
CCNA1 P78396 1/20 0.39
MAPK9 P45984 3/20 0.39
MAPK8 P45983 3/20 0.37
KCNH2 Q12809 1/20 0.37
BRAF P15056 1/20 0.37
CCND3 P30281 3/20 0.36
CDK6 Q00534 3/20 0.36
CCNT1 O60563 2/20 0.36
CDK7 P50613 2/20 0.36
CDK9 P50750 2/20 0.36
CCNH P51946 2/20 0.36
MAPK10 P53779 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812919 0.97 MAPK9 (0.42) IKBKBRETCDK4CCND1CDK1
SCHEMBL5818839 0.96 MAPK9 (0.42) IKBKBRETCDK4CCND1CDK1
SCHEMBL5812866 0.88 MAPK8 (0.39) IKBKBRETCDK4CCND1CDK1
SCHEMBL5815307 0.86 IDH1 (0.40) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL5819508 0.86 KCNH2 (0.47) IKBKBKCNH2
SCHEMBL5819235 0.85 BRAF (0.51) IKBKBCCNA2CDK2CCNA1MAPK9
SCHEMBL5816357 0.84 RET (0.39) IKBKBRETCDK4CCND1CDK1
SCHEMBL5819098 0.84 MAPK14 (0.43) MAPK9MAPK8
SCHEMBL5819462 0.84 CDK1 (0.40) IKBKBRETCDK4CCND1CDK1
SCHEMBL5819146 0.83 DYRK2 (0.39) CDK4CCND1CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed